These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3874287)

  • 1. Aplastic anemia: pathophysiology and management.
    Rothberg H
    J Med Soc N J; 1985 Jun; 82(6):457-62. PubMed ID: 3874287
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe aplastic anemia with a prolonged course of anti-thymocyte globulin.
    Cosimi AB; Peters C; Harmon D; Ellman L
    Transplant Proc; 1982 Dec; 14(4):761-4. PubMed ID: 6984802
    [No Abstract]   [Full Text] [Related]  

  • 3. Antilymphocyte serum therapy in aplastic anemia.
    Prakash O
    J Assoc Physicians India; 1985 Aug; 33(8):555-6. PubMed ID: 3877049
    [No Abstract]   [Full Text] [Related]  

  • 4. "Myelophrenia": its contribution to the management of aplastic anemia.
    Nathan DG
    Prog Clin Biol Res; 1984; 148():xxi-xxx. PubMed ID: 6379655
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of aplastic anemia.
    Gordon-Smith EC
    Prog Clin Biol Res; 1984; 148():335-41. PubMed ID: 6379671
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive treatment of severe aplastic anemia].
    Seip M; Stensvold K; Flaegstad T
    Tidsskr Nor Laegeforen; 1984 Nov; 104(31):2171-3. PubMed ID: 6397874
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antilymphocyte globulin therapy of severe aplastic anemia in childhood].
    Hanada T; Kamota T; Nakahara S; Yamamura H; Ono I; Suzuki T; Shin R; Iwasaki N; Ehara T; Abe T
    Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):561-7. PubMed ID: 3501219
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of aplastic anemia.
    Gale RP
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):117-26. PubMed ID: 3914736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experience in the treatment of severe bone marrow aplasia].
    Zabala P; Díez JL; Cabrera R; Sanjuán I; Barbolla L; Fernández MN
    Sangre (Barc); 1984; 29(5):868-71. PubMed ID: 6395405
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of aplastic anemia with antithymocyte globulin].
    Hatskelzon L; Harman-Baham I; Gaspar N; Liel N; Dvilansky A
    Harefuah; 1990 Jan; 118(2):72-4. PubMed ID: 2312004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes and lymphokines in aplastic anemia: pathogenic role and implications for pathogenesis.
    Young NS; Leonard E; Platanias L
    Blood Cells; 1987; 13(1-2):87-100. PubMed ID: 3311225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
    Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
    Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of suppressor lymphocytes to hematopoietic stem cells in patients with aplastic anemia. Pre-treatment of the bone marrow cells with anti-lymphocyte globulin].
    Hanada T; Abe T
    Rinsho Ketsueki; 1985 Mar; 26(3):357-61. PubMed ID: 3162052
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive therapy of severe aplastic anemia.
    Doney KC; Torok-Storb B; Dahlberg S; Buckner CD; Martin P; Hansen JA; Thomas ED; Storb R
    Prog Clin Biol Res; 1984; 148():259-70. PubMed ID: 6379664
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
    Dubey S; Shukla P; Nityanand S
    Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from severe idiopathic aplastic pancytopenia following antithymocyte globulin therapy.
    Ansari A; Grotte M
    Minn Med; 1986 Jun; 69(6):361-4. PubMed ID: 3489162
    [No Abstract]   [Full Text] [Related]  

  • 17. Aplastic anemia associated with bone marrow suppressor T-cell hyperactivity: successful treatment with antithymocyte globulin.
    Amare M; Abdou NL; Robinson MG; Abdou NI
    Am J Hematol; 1978; 5(1):25-32. PubMed ID: 311583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
    Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM
    Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295
    [No Abstract]   [Full Text] [Related]  

  • 19. Preceding transfusions and marrow graft rejection in dogs and man.
    Weiden PL; Storb R; Thomas ED; Graham TC; Lerner KG; Buckner CD; Fefer A; Neiman PE; Clift RA
    Transplant Proc; 1976 Dec; 8(4):551-4. PubMed ID: 793113
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of severe aplastic anemia: a prospective study of antilymphocyte globulin versus bone marrow transplantation.
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Prog Clin Biol Res; 1984; 148():249-58. PubMed ID: 6379663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.